Purchase Order 75N94022P00672
- Not listed
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $21,688.50 firm fixed-price purchase order contract to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, for the delivery of a DISSOCIATOR WITH HEATERS. This contract has no set-aside designation. Miltenyi Biotec is a global biotechnology company that provides products and services supporting biomedical research, cell therapy development, and...
- This is a $18,639.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services. The contract is for the delivery of Miltenyi's tissue dissociator and associated laboratory equipment. This award is part of a larger indefinite delivery contract (IDC) worth $2.3 million that Miltenyi Biotec holds with the NIH Clinical...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc. for the delivery of a tissue dissociator, a specialized laboratory instrument used for processing biological samples. The $4,881 contract has a completion date of July 31, 2015 and was awarded on July 23, 2015 without any set-aside designation. Miltenyi Biotec is a global biotechnology company that provides instrumentation, reagents, and services to...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of goods. The $211,830 contract is for the provision of Miltenyi's biotechnology products and services to support biomedical research and cell and gene therapy, including instruments, reagents, kits, and antibodies. The award does not have a set-aside...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company, for the delivery of a cell dissociator and cell separator. The award, valued at $58,517.50, was made without a set-aside designation and has an ultimate completion date of September 30, 2017. Miltenyi Biotec is a well-established federal contractor,...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,081.00 firm fixed-price purchase order to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, for a GENTLEMACS OCTO DISSOCIATOR WITH HEATERS scientific instrument and associated freight charges. The award does not utilize a set-aside designation. Miltenyi Biotec specializes in providing scientific instruments, bioreagents, and services to...
- This is a $5,143.50 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. for a GENTLEMACS DISSOCIATOR. The contract has no set-aside designation and was awarded on March 23, 2016 with a completion date of April 5, 2016. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The $5,406.00 firm fixed-price purchase order is for the delivery of a GentleMACS Dissociator instrument, a specialized tissue dissociation system used in biomedical research. The contract is not designated as a set-aside. Miltenyi Biotec is a global biotechnology company that provides scientific instruments,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order contract to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, for the provision of a high performance immunomagnetic cell separation instrument and related products. The $36,368.00 contract does not have a set-aside designation. Miltenyi Biotec specializes in scientific instruments, cell separation technology,...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Miltenyi Biotec, Inc. in the amount of $24,646.00. The contract is for the delivery of Miltenyi's GentleMACS instruments and associated products, which are used for cell separation, analysis, and processing in biomedical research. Miltenyi Biotec is a global biotechnology company that provides specialized scientific equipment, reagents, and...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of scientific instruments and reagents. The $24,857.50 contract is for the provision of a DISSOCIATOR INSTRUMENT WITH HEATING UNITS, with a period of performance ending on October 30, 2022. This award is not associated with a larger contract vehicle and does not have a set-aside designation. Miltenyi Biotec is a global leader in cell separation, analysis, and processing technologies, supplying specialized equipment and consumables to numerous federal research agencies within the NIH ecosystem, including the NIH Clinical Center, National Cancer Institute, and National Institute of Allergy and Infectious Diseases. The company holds a significant sole-source Indefinite Delivery Contract with the NIH Clinical Center, valued at $4.6 million, for the supply of proprietary cell isolation reagents and consumables required for the center's cell processing and manufacturing capabilities supporting investigational cell therapy product development.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.9k | 8/18/22 |